Literature DB >> 18650978

The role of impaired sympathetic nerve function in enhancing coronary vasoconstriction in patients with hypertrophic cardiomyopathy.

Shinro Matsuo1, Tetsuya Matsumoto, Ichiro Nakae, Minoru Horie.   

Abstract

Coronary vasospasm and diminished coronary blood flow reserve have often been reported in patients with hypertrophic cardiomyopathy (HCM). However, the mechanism of coronary spasm in HCM is unknown. Thus, coronary endothelial function and sympathetic nerve function in 11 patients with HCM and 11 control patients matched for age and sex were examined. The diameter of the left anterior descending coronary artery was assessed by quantitative coronary angiography, and the change in coronary blood flow was estimated using an intracoronary Doppler flow wire. To assess myocardial sympathetic nerve function, metaiodobenzylguanidine images - 15 min and 180 min after the injection of (123)I-metaiodoben-zylguanidine at a dosage of 111 MBq - were obtained, and the heart to mediastinum (H/M) count ratio and the washout rate (WR) were calculated. The H/M ratio was significantly lower in patients with HCM (2.1+/-0.3) than in control patients (2.6+/-0.4) (P<0.01). In addition, the WR was higher in patients with HCM (35+/-6%) than in control patients (28+/-3%) (P<0.01). The HCM subjects with coronary spasm had lower H/M ratios and higher WRs than HCM subjects without coronary spasm (P<0.05, respectively). In conclusion, impaired sympathetic nerve function may be associated with coronary vasospasm and diminished coronary blood flow reserve in HCM.

Entities:  

Keywords:  Hypertrophic cardiomyopathy; Metaiodobenzylguanidine

Year:  2007        PMID: 18650978      PMCID: PMC2359623     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  30 in total

1.  Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy--Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography.

Authors:  J Yamazaki; H Muto; T Kabano; S Yamashina; S Nanjo; A Inoue
Journal:  Am Heart J       Date:  2001-04       Impact factor: 4.749

2.  Myocardial metabolic abnormalities in hypertrophic cardiomyopathy assessed by iodine-123-labeled beta-methyl-branched fatty acid myocardial scintigraphy and its relation to exercise-induced ischemia.

Authors:  S Matsuo; Y Nakamura; M Takahashi; K Mitsunami; M Kinoshita
Journal:  Jpn Circ J       Date:  1998-03

3.  Value of iodine-123 metaiodobenzylguanidine scintigraphy in patients with vasospastic angina.

Authors:  J Taki; S Yasuhara; T Takamatsu; K Nakajima; R Tatami; S Ishise; I Matsunari; T Takayama; N Tonami
Journal:  Eur J Nucl Med       Date:  1998-03

4.  Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation.

Authors:  R Krams; M J Kofflard; D J Duncker; C Von Birgelen; S Carlier; M Kliffen; F J ten Cate; P W Serruys
Journal:  Circulation       Date:  1998-01-27       Impact factor: 29.690

5.  Quantitative analysis of 123I-meta-iodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy.

Authors:  K Nakajima; H Bunko; J Taki; M Shimizu; A Muramori; K Hisada
Journal:  Am Heart J       Date:  1990-06       Impact factor: 4.749

6.  The relationship between flow-mediated brachial artery vasodilation and coronary vasomotor responses to bradykinin: comparison with those to acetylcholine.

Authors:  Shinro Matsuo; Tetsuya Matsumoto; Hiroyuki Takashima; Naoto Ohira; Tetsunobu Yamane; Yo Yasuda; Yasuhiro Tarutani; Minoru Horie
Journal:  J Cardiovasc Pharmacol       Date:  2004-08       Impact factor: 3.105

7.  Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy.

Authors:  B J Maron; J K Wolfson; S E Epstein; W C Roberts
Journal:  J Am Coll Cardiol       Date:  1986-09       Impact factor: 24.094

8.  Myocardial catecholamines in hypertrophic and dilated (congestive) cardiomyopathy: a biopsy study.

Authors:  C Kawai; Y Yui; T Hoshino; S Sasayama; A Matsumori
Journal:  J Am Coll Cardiol       Date:  1983-11       Impact factor: 24.094

9.  Modulation of left ventricular iodine-125-MIBG accumulation in cardiomyopathic Syrian hamsters using the renin-angiotensin system.

Authors:  H Takatsu; Y Uno; H Fujiwara
Journal:  J Nucl Med       Date:  1995-06       Impact factor: 10.057

10.  Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography.

Authors:  P T O'Gara; R O Bonow; B J Maron; B A Damske; A Van Lingen; S L Bacharach; S M Larson; S E Epstein
Journal:  Circulation       Date:  1987-12       Impact factor: 29.690

View more
  1 in total

1.  Clinical use of nuclear cardiology in the assessment of heart failure.

Authors:  Shinro Matsuo; Kenichi Nakajima; Seigo Kinuya
Journal:  World J Cardiol       Date:  2010-10-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.